SLNO Share Price Performance
US$65.65
9.51 (16.94%)
Price US$65.65
Share PriceUS$65.65
Soleno Therapeutics, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 13 Fair Values set on narratives written by author
SLNO Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Soleno Therapeutics, Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 04, 2025
- -3.41
- 97.87%
- -554.49%
- 20.8%
About SLNO
- Founded
- 1999
- Employees
- 133
- CEO
- WebsiteView website
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.
